Paolo Gresele

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Medicine, Pharmacology, Pharmacotherapy +10

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

Vittorio Pengo, Gentian Denas, Giacomo Zoppellaro et al. · Blood · 2018 · 798 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

Vittorio Pengo, Amelia Ruffatti, Cristina Legnani et al. · Journal of Thrombosis and Haemostasis · 2009 · 619 citations · Full text

Medicine, Hematology, Internal Medicine +12

Whole-genome sequencing of patients with rare diseases in a national health system

Ernest Turro, Karyn Mégy, Olga Shamardina et al. · Nature · 2020 · 582 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study

Vittorio Pengo, Amelia Ruffatti, Cristina Legnani et al. · Blood · 2011 · 459 citations · Full text

Medicine, Hematology, Immunology +15